Clinical Trial Update: Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial of sunitinib in patients with unresectable liver cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED